Altium Capital Management LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Altium Capital Management LLC reported 57 stock positions worth $334.9 million. Its top holding was Vera Therapeutics (VERA) at 9.0% of the portfolio, followed by Adma Biologics (ADMA, 8.1%) and Sarepta Therapeutics (SRPT, 6.3%). Compared with Q2 2024, it opened 30 new positions, sold out of 18, added to 7 and reduced 12. The biggest buy was a new position in Edwards Lifesciences (EW) and the biggest sale an exit from Alimera Sciences (ALIM).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001746382
- Portfolio Value
- $334.9M (Q3 2024)
- SEC Filing
- 0001420506-24-002530 ↗ filed Nov 14, 2024
Holdings Value
Holdings 57 stocks · $334.9M
| VERA Vera Therapeutics Inc. | 9.03% | 684,000 | $30.2M | Reduce -4.2% |
| ADMA Adma Biologics Inc. | 8.12% | 1,360,000 | $27.2M | Reduce -9.9% |
| SRPT Sarepta Therapeutics Inc. | 6.34% | 170,000 | $21.2M | Add +107.6% |
| EW Edwards Lifesciences Corp. | 4.37% | 222,000 | $14.6M | New |
| XENE Xenon Pharmaceuticals Inc. | 4.24% | 360,600 | $14.2M | No change |
| ZVRA Zevra Therapeutics Inc. | 3.52% | 1,700,000 | $11.8M | Add +46.3% |
| ITCI Intra-Cellular Therapies Inc. | 3.36% | 154,000 | $11.3M | Reduce -20.2% |
| SLNO Soleno Therapeutics Inc. | 3.21% | 212,909 | $10.7M | No change |
| GKOS Glaukos Corp. | 3.00% | 77,000 | $10.0M | New |
| INSM Insmed Inc. | 2.83% | 130,000 | $9.5M | Reduce -31.6% |
| MMSI Merit Medical Systems Inc. | 2.51% | 85,000 | $8.4M | New |
| RZLT Rezolute Inc. | 2.46% | 1,700,000 | $8.2M | No change |
| PCVX Vaxcyte Inc. | 2.46% | 72,000 | $8.2M | New |
| AVDL Avadel Pharmaceuticals Ltd. | 2.39% | 610,000 | $8.0M | No change |
| VKTX Viking Therapeutics Inc. | 2.38% | 126,000 | $8.0M | Add +3.3% |
| CPRX Catalyst Pharmaceuticals Inc. | 2.29% | 385,000 | $7.7M | Reduce -23.0% |
| CTNM Contineum Therapeutics Inc. Class A | 2.11% | 369,126 | $7.1M | Reduce -14.0% |
| ARWR Arrowhead Pharmaceuticals Inc. | 2.05% | 355,000 | $6.9M | New |
| SVRA Savara Inc. | 1.99% | 1,575,000 | $6.7M | No change |
| IRTC Irhythm Holdings Inc. | 1.91% | 86,000 | $6.4M | New |
| EOLS Evolus Inc. | 1.72% | 355,000 | $5.8M | New |
| ESTA Establishment Labs Holdings | 1.69% | 131,000 | $5.7M | New |
| RXST Rxsight Inc. | 1.65% | 112,000 | $5.5M | New |
| AXSM Axsome Therapeutics Inc. | 1.56% | 58,000 | $5.2M | Add +16.0% |
| SKYE Skye Bioscience Inc. | 1.54% | 1,315,146 | $5.1M | Reduce -2.6% |
| XTNT Xtant Medical Holdings Inc. | 1.50% | 7,415,413 | $5.0M | No change |
| LRMR Larimar Therapeutics Inc. | 1.36% | 693,000 | $4.5M | No change |
| CAPR Capricor Therapeutics Inc. | 1.29% | 285,000 | $4.3M | New |
| LUNG Pulmonx Corp. | 1.24% | 500,000 | $4.1M | New |
| CRBP Corbus Pharmaceuticals Holdi | 1.20% | 195,000 | $4.0M | New |
| KROS Keros Therapeutics Inc. | 1.20% | 69,000 | $4.0M | New |
| REAL The Realreal Inc. filed as THE REALREAL INC | 1.19% | 1,270,000 | $4.0M | Add +1.6% |
| CATX Perspective Therapeutics Inc. | 1.16% | 290,000 | $3.9M | Add +51.5% |
| BHVN Biohaven Ltd. | 1.12% | 75,000 | $3.7M | New |
| ORIC Oric Pharmaceuticals Inc. | 1.09% | 355,000 | $3.6M | Reduce -12.3% |
| GPCR Structure Therapeutics Inc. | 0.92% | 70,000 | $3.1M | New |
| OTLK Outlook Therapeutics Inc. | 0.86% | 541,549 | $2.9M | Add +7.9% |
| VCEL Vericel Corp. | 0.86% | 68,000 | $2.9M | New |
| HELP Cybin Inc. | 0.84% | 317,000 | $2.8M | Reduce -13.1% |
| TERN Terns Pharmaceuticals Inc. | 0.82% | 330,000 | $2.8M | New |
| OCGN Ocugen Inc. | 0.70% | 2,350,000 | $2.3M | New |
| MLTX Moonlake Immunotherapeutics | 0.60% | 40,000 | $2.0M | Reduce -65.2% |
| BCYC Bicycle Therapeutics PLC-ADR | 0.57% | 85,000 | $1.9M | New |
| VERU Veru Inc. | 0.47% | 2,028,534 | $1.6M | Reduce -10.9% |
| ATRC Atricure Inc. | 0.45% | 54,000 | $1.5M | New |
| CTMX Cytomx Therapeutics Inc. | 0.32% | 915,000 | $1.1M | New |
| NVNO Envveno Medical Corporation | 0.24% | 238,920 | $803K | New |
| TPST Tempest Therapeutics Inc. | 0.23% | 545,000 | $763K | New |
| PMN Promis Neurosciences Inc. | 0.22% | 581,395 | $727K | New |
| MIST Milestone Pharmaceuticals Inc. | 0.20% | 440,000 | $669K | Reduce -56.5% |
| KPTI Karyopharm Therapeutics Inc. | 0.18% | 740,000 | $614K | No change |
| UNICYCIVE THERAPEUTICS INC | 0.18% | 1,473,000 | $601K | New |
| CLRB Cellectar Biosciences Inc. | 0.14% | 215,000 | $460K | New |
| SRXH SRX Global Inc. filed as BETTER CHOICE CO INC | 0.08% | 133,117 | $278K | New |
| EXPION360 INC | 0.03% | 2,057,494 | $106K | New |
| SCPX Scorpius Holdings Inc. | 0.02% | 88,291 | $64K | New |
| NKTR Nektar Therapeutics | 0.00% | 11,419 | $15K | New |
Options reported separately and not counted above: ANVS puts ($1.9M), LRMR calls ($1.3M), APLT puts ($477K), XENE calls ($370K).
Other holdings (18): bonds, preferreds, convertibles and warrants · $779K (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| FATBW Fat Brands Inc. -CW25 | *W EXP 07/16/202 | 200,000 | $499K | No change |
| NXGLW Nexgel Inc. -CW26 | *W EXP 12/27/202 | 225,000 | $91K | No change |
| RCKTW Rocket Pharmaceuticals in-27 | *W EXP 09/02/202 | 731,561 | $51K | No change |
| ONFOW Onfolio Holdings Inc. -27 | *W EXP 01/02/202 | 200,000 | $34K | No change |
| WLDSW Wearable Devices Ltd. - 27 | *W EXP 09/14/202 | 1,411,600 | $28K | No change |
| MOBXW Chavrant Capital Acq -CW23 | *W EXP 12/21/202 | 150,000 | $22K | No change |
| CINGW Cingulate -CW23 | *W EXP 12/10/202 | 270,000 | $19K | No change |
| NXLIW Nexalin Technology Inc.- 27 | *W EXP 99/99/999 | 105,000 | $8K | No change |
| BNCWW Cea Industries Inc. -CW27 | *W EXP 02/11/202 | 250,000 | $6K | No change |
| VSEEW Digital Health Acquist-CW23 | *W EXP 99/99/999 | 150,000 | $6K | No change |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $2K | No change |
| NEXRW Jeffs Brands Ltd. -27 | *W EXP 08/26/202 | 68,681 | $2K | No change |
| NLSPW NLS Pharmaceutics Ltd. -CW25 | *W EXP 02/02/202 | 200,000 | $2K | No change |
| CYCUW Cycurion Inc.-CW27 | *W EXP 02/13/203 | 100,000 | $2K | No change |
| CDTTW Murphy Canyon Acq-CW27 | *W EXP 09/22/202 | 100,000 | $2K | No change |
| MITAW Coliseum Acquisition A -CW28 | *W EXP 08/22/202 | 28,333 | $1K | No change |
| SRZNW Surrozen Inc.-CW25 | *W EXP 08/01/203 | 82,233 | $1K | No change |
| TCBWF TC Biopharm Holdings Ltd. | *W EXP 02/10/202 | 18,823 | $343 | No change |
Total filed on the 13F, all lines: $335.7M.
Portfolio Sells Q2 2024 → Q3 2024
| ALIM Alimera Sciences Inc. | Sold out | 0.00% | −4.96 |
| ARGX Argenx SE - ADR | Sold out | 0.00% | −4.10 |
| SKYE Skye Bioscience Inc. | Reduce -2.6% | 1.54% | −2.95 |
| ASND Ascendis Pharma A/S | Sold out | 0.00% | −2.83 |
| INSM Insmed Inc. | Reduce -31.6% | 2.83% | −2.44 |
| ITCI Intra-Cellular Therapies Inc. | Reduce -20.2% | 3.36% | −2.12 |
| VERA Vera Therapeutics Inc. | Reduce -4.2% | 9.03% | −1.68 |
| MLTX Moonlake Immunotherapeutics | Reduce -65.2% | 0.60% | −1.49 |
| RARE Ultragenyx Pharmaceutical Inc. | Sold out | 0.00% | −1.19 |
| CTNM Contineum Therapeutics Inc. Class A | Reduce -14.0% | 2.11% | −1.03 |
| CPRX Catalyst Pharmaceuticals Inc. | Reduce -23.0% | 2.29% | −0.93 |
| HELP Cybin Inc. | Reduce -13.1% | 0.84% | −0.73 |
| ACHV Achieve Life Sciences Inc. | Sold out | 0.00% | −0.42 |
| ALLURION TECHNOLOGIES INC | Sold out | 0.00% | −0.40 |
| MIST Milestone Pharmaceuticals Inc. | Reduce -56.5% | 0.20% | −0.35 |
| BIOVIE INC | Sold out | 0.00% | −0.33 |
| VERU Veru Inc. | Reduce -10.9% | 0.47% | −0.33 |
| CNTX Context Therapeutics Inc. | Sold out | 0.00% | −0.30 |
| APRE Aprea Therapeutics Inc. | Sold out | 0.00% | −0.23 |
| SPRB Spruce Biosciences Inc. | Sold out | 0.00% | −0.17 |
| EVOK Evoke Pharma Inc. | Sold out | 0.00% | −0.15 |
| BOLD Boundless Bio Inc. | Sold out | 0.00% | −0.13 |
| ORIC Oric Pharmaceuticals Inc. | Reduce -12.3% | 1.09% | −0.10 |
| LXRX Lexicon Pharmaceuticals Inc. | Sold out | 0.00% | −0.09 |
| INTELLIGENT BIO SOLUTIONS IN | Sold out | 0.00% | −0.07 |
| PMNT Perfect Moment Ltd. | Sold out | 0.00% | −0.06 |
| CETX Cemtrex Inc. | Sold out | 0.00% | −0.03 |
| QUOIN PHARMACEUTICALS LTD | Sold out | 0.00% | −0.02 |
| APPLIED DNA SCIENCES INC | Sold out | 0.00% | −0.01 |
| ADMA Adma Biologics Inc. | Reduce -9.9% | 8.12% | +1.12 |
Portfolio Buys Q2 2024 → Q3 2024
| EW Edwards Lifesciences Corp. | New | 4.37% | +4.37 |
| GKOS Glaukos Corp. | New | 3.00% | +3.00 |
| MMSI Merit Medical Systems Inc. | New | 2.51% | +2.51 |
| PCVX Vaxcyte Inc. | New | 2.46% | +2.46 |
| ARWR Arrowhead Pharmaceuticals Inc. | New | 2.05% | +2.05 |
| IRTC Irhythm Holdings Inc. | New | 1.91% | +1.91 |
| EOLS Evolus Inc. | New | 1.72% | +1.72 |
| ESTA Establishment Labs Holdings | New | 1.69% | +1.69 |
| RXST Rxsight Inc. | New | 1.65% | +1.65 |
| CAPR Capricor Therapeutics Inc. | New | 1.29% | +1.29 |
| LUNG Pulmonx Corp. | New | 1.24% | +1.24 |
| CRBP Corbus Pharmaceuticals Holdi | New | 1.20% | +1.20 |
| KROS Keros Therapeutics Inc. | New | 1.20% | +1.20 |
| ZVRA Zevra Therapeutics Inc. | Add +46.3% | 3.52% | +1.16 |
| BHVN Biohaven Ltd. | New | 1.12% | +1.12 |
| SRPT Sarepta Therapeutics Inc. | Add +107.6% | 6.34% | +0.97 |
| GPCR Structure Therapeutics Inc. | New | 0.92% | +0.92 |
| VCEL Vericel Corp. | New | 0.86% | +0.86 |
| TERN Terns Pharmaceuticals Inc. | New | 0.82% | +0.82 |
| OCGN Ocugen Inc. | New | 0.70% | +0.70 |
| BCYC Bicycle Therapeutics PLC-ADR | New | 0.57% | +0.57 |
| ATRC Atricure Inc. | New | 0.45% | +0.45 |
| CATX Perspective Therapeutics Inc. | Add +51.5% | 1.16% | +0.36 |
| CTMX Cytomx Therapeutics Inc. | New | 0.32% | +0.32 |
| NVNO Envveno Medical Corporation | New | 0.24% | +0.24 |
| TPST Tempest Therapeutics Inc. | New | 0.23% | +0.23 |
| PMN Promis Neurosciences Inc. | New | 0.22% | +0.22 |
| UNICYCIVE THERAPEUTICS INC | New | 0.18% | +0.18 |
| CLRB Cellectar Biosciences Inc. | New | 0.14% | +0.14 |
| SRXH SRX Global Inc. | New | 0.08% | +0.08 |
| EXPION360 INC | New | 0.03% | +0.03 |
| SCPX Scorpius Holdings Inc. | New | 0.02% | +0.02 |
| NKTR Nektar Therapeutics | New | 0.00% | +0.00 |
| AXSM Axsome Therapeutics Inc. | Add +16.0% | 1.56% | −0.11 |
| VKTX Viking Therapeutics Inc. | Add +3.3% | 2.38% | −0.30 |
| REAL The Realreal Inc. | Add +1.6% | 1.19% | −0.46 |
| OTLK Outlook Therapeutics Inc. | Add +7.9% | 0.86% | −0.67 |
Options Activity Q2 2024 → Q3 2024
| ANVS Annovis Bio | put | Add +52.2% | 236,400 | $1.9M |
| RAPT THERAPEUTICS INC | call | Sold out | 200,000 | $610Kbefore exit |
| APLT Applied Therapeutics Inc. | put | New | 56,100 | $477K |
| XENE Xenon Pharmaceuticals Inc. | call | New | 9,400 | $370K |
| SVRA Savara Inc. | call | Sold out | 20,000 | $81Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q2 2024 → Q3 2024
| SLNWF Selina Hospitality PLC-27 | *W EXP 10/27/202 | Sold out | 101,439 | $1Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $47.5M | RMT, ASA, RVT, NBXG, PDX |
| Q1 2026 | 19 | $42.0M | PDX, ASA, RVT, XPCQX, GAM |
| Q4 2025 | 18 | $25.3M | ASA, RVT, PDX, NBXG, XPCQX |
| Q3 2025 | 1 | $628K | CNSY |
| Q2 2025 | 0 | $0 | |
| Q1 2025Amended | 22 | $34.4M | ZVRA, EOLS, XTNT, AVDL, CTNM |
| Q4 2024 | 61 | $321.1M | ADMA, VERA, SRPT, ZVRA, ESTA |
| Q3 2024 | 57 | $334.9M | VERA, ADMA, SRPT, EW, XENE |
| Q2 2024 | 45 | $241.2M | VERA, ADMA, XENE, ITCI, SRPT |
| Q1 2024 | 46 | $222.3M | VERA, XENE, AXSM, ADMA, ALIM |